IndiaMTF — home
Stock

NATCOPHARM

Natco Pharma Limited
Health Technology

Daily Margin Trading Facility book for NATCOPHARM across NSE and BSE, from 01 Jan 2025. All figures in ₹ crore, derived from exchange public disclosures.

Funded value
₹190 Cr
as of 10 Sep 2026
Rank in book
#195
407 days tracked
Share of book
0.12%
of the whole NSE + BSE book
Peak funded
₹260 Cr
on 27 Jan 2025
Largest single-day addition
+₹26 Cr
on 15 Oct 2025
Largest single-day unwind
−₹21 Cr
on 13 Feb 2025

NSE & BSE split

How NATCOPHARM’s funded book divides across the two exchanges, as of 10 Sep 2026.
NSE
NSE ₹184 Cr · 96.6%BSE ₹6 Cr · 3.4%

MTF vs Price

Margin-funded outstanding for NATCOPHARM in ₹ crore against the closing price, adjusted for splits and bonuses. Each window uses the same reference date as the table below, so the two agree. Funded value moves with the price on its own, so the line under the chart reads the share count instead — that is what shows whether more stock is genuinely being borrowed against.
MTF book (₹ Cr)

Price and liquidity

Adjusted for splits and bonuses, so a change across a corporate action reflects the market rather than the share count.
Last close
₹815.35
as of 11 Sep 2026
Price, 30 days
−11.1%
adjusted for splits and bonuses
Delivery, 20-day avg
50.4%
of traded volume actually settled
Sessions to unwind
10.4
of average deliverable volume
Shares under margin divided by average daily deliverable volume over the last 20 sessions.

Book, shares and price by window

Funded value moves with the price on its own, so the share count is what shows whether more stock is actually being borrowed against. The last column reads the two together.
WindowBook ΔBook %SharesPriceReading
1 day+₹1+0.6%+0.8%
+14,600
−0.9%building as it falls
10 days+₹10+5.7%+7.6%
+1,36,210
−4.5%building as it falls
30 days+₹30+18.7%+24.1%
+3,74,907
−12.0%building as it falls
90 days+₹5+2.8%+7.8%
+1,40,713
−5.2%building as it falls
180 days+₹41+27.4%+30.0%
+4,46,187
−18.4%building as it falls
1 year−₹50−20.9%−21.6%
−5,34,417
−6.4%unwinding as it falls
Price is as of 11 Sep 2026; the MTF book is as of 10 Sep 2026. Exchanges publish the margin file a day after the market data, and the comparison above uses the MTF date for both sides.

Shares under margin

Number of shares funded via MTF over time (NSE + BSE combined).

Rank trajectory

Where NATCOPHARM has sat in the funded-value ranking each day (1 = most funded). Lower is more prominent.

NATCOPHARM — last 30 trading days

Combined NSE + BSE funded value, day-on-day change, share of the whole book, and rank. Newest first.
DateCombined (₹ Cr)Day Δ (₹ Cr)% of bookRank
10 Sep 2026190+₹10.12%195
09 Sep 2026189+₹00.12%197
08 Sep 2026189+₹20.12%198
07 Sep 2026187+₹10.12%199
04 Sep 2026186+₹40.12%199
03 Sep 2026182+₹10.12%202
02 Sep 2026182+₹00.12%205
01 Sep 2026182−₹00.12%204
31 Aug 2026182+₹10.12%201
28 Aug 2026181+₹20.12%199
27 Aug 2026180+₹20.12%203
26 Aug 2026178+₹30.12%203
25 Aug 2026176+₹40.12%203
24 Aug 2026172+₹10.11%214
21 Aug 2026171−₹20.12%212
20 Aug 2026173+₹20.12%209
19 Aug 2026171+₹20.12%213
18 Aug 2026169−₹10.11%215
17 Aug 2026170−₹30.12%211
14 Aug 2026173+₹40.12%209
13 Aug 2026169+₹20.12%215
12 Aug 2026168+₹30.11%215
11 Aug 2026165+₹10.11%216
10 Aug 2026164+₹10.11%220
07 Aug 2026163−₹00.11%219
06 Aug 2026163+₹00.11%220
05 Aug 2026163+₹10.11%220
04 Aug 2026162+₹30.11%222
03 Aug 2026159+₹00.11%226
31 Jul 2026158—0.11%229

NATCOPHARM within Health Technology

Ranked #8 of 61 funded Health Technology stocks, carrying 3.0% of that sector’s margin book. Nearest names by funded value:
#StockMTF book (₹ Cr)% of sector
6DIVISLAB
Divi's Laboratories Limited
₹2664.2%
7GLAND
Gland Pharma Limited
₹2023.2%
8NATCOPHARM
Natco Pharma Limited
₹1903.0%
9DRREDDY
Dr. Reddy's Laboratories Limited
₹1702.7%
10LUPIN
Lupin Limited
₹1702.7%

All Health Technology stocks and how the sector has moved →

Disclaimer. Data sourced from daily margin trading disclosure provided by NSE and BSE. This website and page are meant for educational and information only — not investment advice. MTF is leveraged and can amplify losses. Rules, margins, rates and eligible-stock lists change; verify current details with your broker and SEBI/exchange circulars. IndiaMTF.com is not a SEBI-registered intermediary, broker, or investment adviser and has no affiliation with SEBI, NSE or BSE. Figures are reproduced from publicly disclosed exchange data, may be delayed or revised, and should be independently verified before any trading decision. Consult a SEBI-registered investment adviser before investing.